145439-97-0

Basic information

• Product Name: (S)-2,2,2-trifluoro-N-[2-hydroxy-2-methyl-1-phenylpropyl]acetamide
• Synonyms: (S)-2,2,2-trifluoro-N-[2-hydroxy-2-methyl-1-phenylpropyl]acetamide
• CAS NO: 145439-97-0
• Molecular Weight: 261.244
• Mol File: 145439-97-0.mol

Chemical Properties

• CAS DataBase Reference: (S)-2,2,2-trifluoro-N-[2-hydroxy-2-methyl-1-phenylpropyl]acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-2,2,2-trifluoro-N-[2-hydroxy-2-methyl-1-phenylpropyl]acetamide(145439-97-0)
• EPA Substance Registry System: (S)-2,2,2-trifluoro-N-[2-hydroxy-2-methyl-1-phenylpropyl]acetamide(145439-97-0)

Safety Data

• Hazardous Substances Data: 145439-97-0(Hazardous Substances Data)

Upstream product

• 6591-61-3 (S)-Phenylglycine methyl ester 
• 2935-35-5 (S)-2-phenylglycine 
• 917-64-6 methyl magnesium iodide 
• 145513-97-9 (S)-(+)-2-phenyl-N-(trifluoroacetyl)glycine methyl ester 
• 75-16-1 methylmagnesium bromide 

Downstream Products

• 145439-95-8 N,N'-Bis-((S)-2-hydroxy-2-methyl-1-phenyl-propyl)-2,2-dimethyl-malonamide 
• 145439-96-9 C₂₅H₃₀N₂O₂ 
• 639057-74-2 bis((S)-5,5-dimethyl-4-phenyl-4,5-dihydrooxazol-2-yl)methane 
• 110480-86-9 (1S)-1-amino-2-methyl-1-phenylpropan-2-ol 

Relevant articles and documents

HIGHLY ENANTIOSELECTIVE CATALYTIC DIELS-ALDER ADDITION PROMOTED BY A CHIRAL BIS(OXAZOLINE)-MAGNESIUM COMPLEX

The new chiral bis(oxazoline) ligand 8 has been synthesized from (S)-phenylglycine and has been shown to form effective catalysts for enantioselective Diels-Alder addition in combination with ferric iodide, magnesium iodide or magnesium tetraphenylborate.Catalytic activation of the dienophile, 3-acryloyl-1,3-oxazolidine-2-one (4), in the magnesium system is proposed to involve tetrahedrally coordinated magnesium in a dispositive complex (10).

Substituted pteridines for the treatment of inflammatory diseases

The invention relates to new pteridines which are suitable for the treatment of respiratory or gastrointestinal complaints or diseases, inflammatory diseases of the joints, skin or eyes, diseases of the peripheral or central nervous system or cancers, as

C2-Symmetric Bis(oxazolinato)lanthanide Catalysts for Enantioselective Intramolecular Hydroamination/Cyclization

C2-symmetric bis(oxazolinato)lanthanide complexes of the type [(4R,5S)-Ph2Box]La[N(TMS)2]2, [(4S,5R)-Ar 2Box]La[N(TMS)2]2, and [(4S)-Ph-5,5-Me 2Box]La[N(TMS)2/su